Exponential growth in production demand sees Cardea eyeing the millionth biosensor in 2023

SAN DIEGO, Aug. 16, 2022 /PRNewswire/ — Since its founding in late 2013, Cardea’s scientists have been pioneering the development of the world’s first mass produced biocompatible semiconductor – the BPU (Biosignal Processing Unit) – also called a graphene Field Effect Transistor (gFET)…

Click here to view original post